|
|
2006年9月回国来到复旦大学附属肿瘤医院乳腺癌研究所工作。作为课题负责人,主持了多项国家自然科学基金,以及教育部新世纪优秀人才基金、上海市浦江人才计划基金、上海市卫生计生系统优秀学科带头人基金、上海市教委科研创新项目、教育部留学回国人员启动基金、上海市自然科学基金等多项省部级基金;已在国内外期刊杂志上发表论文40余篇,论文发表于Theranostics、J Biol Chem、Mol Cell Biol、Breast Cancer Res Treat、Biochem Pharmacol 等学术杂志;担任国家自然科学基金等项目的通讯评议专家;担任8家SCI杂志审稿人,还担任中国抗癌协会抗癌药物专业委员会委员、上海市抗癌协会乳腺癌专业委员等社会学术职务。
研究领域:
主要从事乳腺癌转移相关的研究,目前主要研究方向包括:
1.脂质代谢与乳腺癌转移;
2.线粒体相关基因在乳腺癌转移中的作用;
3.转录因子与乳腺癌发生发展的研究。
研究团队:
小组成员共7位:孙荷芬(研究助理)、李良东(博士研究生)、李璇(博士研究生)、徐宝金(博士研究生)、顾筱莉(博士研究生)。
代表性论著:
-
Liu Y#, Sun H, Li X, Liu Q, Zhao Y, Li L,
Xu B, Hou Y*, Jin W*. Identification of a
Three-RNA Binding Proteins (RBPs) Signature Predicting Prognosis for Breast
Cancer. Front Oncol. 2021 Jul 12; 11:663556.
-
Li X#, Sun H#, Liu Q, Liu Y, Hou
Y*, Jin W*. A pharmacophore-based
classification better predicts the outcomes of HER2-negative breast cancer
patients receiving the anthracycline- and/or taxane-based neoadjuvant
chemotherapy. Cancer Med. 2021 Jul; 10(13):4658-4674.
-
Fu W#, Sun H, Zhao Y, Chen M, Yang X, Liu
Y, Jin W*. BCAP31 drives TNBC development by modulating
ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation. Theranostics.
2019 Aug 21;9(22):6468-6484.
-
Liu QQ#, Sun HF#, Yang XL, Chen
MT, Liu Y, Zhao Y, Zhao YY, Jin W*. Survival following
radiotherapy in young women with localized early-stage breast cancer according
to molecular subtypes. Cancer Med. 2019 Jun; 8(6):2840-2857.
-
Huang S#, Chi Y#, Qin Y#,
Wang Z, Xiu B, Su Y, Guo R, Guo L, Sun H, Zeng C, Zhou S, Hu X, Liu S, Shao Z,
Wu Z, Wei J*, Wu J*. CAPG enhances breast cancer
metastasis by competing with PRMT5 to modulate STC-1 transcription. Theranostics,
2018; 8(9): 2549-2564.
-
Chen M#, Zhao Y, Yang X, Zhao Y, Liu Q, Liu
Y, Hou Y, Sun H*, Jin W*. NSDHL promotes
triple-negative breast cancer metastasis through the TGFβ signaling pathway and
cholesterol biosynthesis. Breast Cancer Res Treat. 2021
Jun;187(2):349-362.
-
Zhao Y#, Sun HF#, Chen MT, Gao
SP, Li LD, Jiang HL, Jin W*. Clinicopathological
characteristics and survival outcomes in Paget disease: a SEER population-based
study. Cancer Med, 2018 Jun; 7(6):2307-2318.
-
Chen MT#, Sun HF#, Zhao Y, Fu
WY, Yang LP, Gao SP, Li LD, Jiang HL, Jin W*. Comparison of
patterns and prognosis among distant metastatic breast cancer patients by age
groups: a SEER population-based analysis. Sci Rep, 2017
Aug 23; 7(1):9254.
-
Gao SP#, Sun HF#, Li LD, Fu WY, Jin
W*. UHRF1 promotes breast cancer progression by suppressing KLF17
expression by hypermethylating its promoter. Am J Cancer Res,
2017 Jul 1; 7(7):1554-1565.
-
Gao SP#, Sun HF#, Fu WY, Li LD,
Zhao Y, Chen MT, Jin W*. High expression of COX5B is
associated with poor prognosis in breast cancer. Future Oncol,
2017 Aug;13(19):1711-1719.
|